About

Designing a universal Mycoplasma chassis that can be deployed as single- or multi-vaccine in a range of animal hosts

 

Annually, infections caused by Mycoplasma species in poultry, cows, and pigs result in multimillion Euro losses in the USA and Europe.

There is no effective vaccination against many Mycoplasmas that infect pets, humans and farm animals (e.g. Mycoplasma bovis cow infection). Furthermore, most Mycoplasmas are difficult to grow in axenic culture, requiring a complex media that includes animal serum.

Consequently, even in those cases in which effective vaccines are available (namely, M. hyopneumoniae in pigs and M. gallisepticum and M. synoviae in poultry), the production process of the vaccines is challenging. Here, we will capitalize on our extensive system biology knowledge of M. pneumoniae and on cutting-edge synthetic biology methodologies to design a universal Mycoplasma chassis that can be deployed as single- or multi-vaccine in a range of animal hosts.

 

 


For more detail, click through to "In Depth"

 

For an overview of the the MycoSynVac Project, you can also have a look to our videos

 

 

 

MycoSynVac the documentary